Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Divya Suthar"'
Autor:
Shilpa Vyas-Read, Nidhy P. Varghese, Divya Suthar, Carl Backes, Satyan Lakshminrusimha, Christopher J. Petit, Philip T. Levy
Publikováno v:
Children, Vol 9, Iss 5, p 713 (2022)
Pulmonary vein stenosis (PVS) has emerged as a critical problem in premature infants with persistent respiratory diseases, particularly bronchopulmonary dysplasia (BPD). As a parenchymal lung disease, BPD also influences vascular development with ass
Externí odkaz:
https://doaj.org/article/b174e47c1f604f68987d037e074ade5f
Autor:
Divya Suthar, Michael Briones, Rosemary Gray, Christopher J. Petit, Jay D. Patel, Shannon Jones
Publikováno v:
Current Treatment Options in Pediatrics. 6:170-181
Pulmonary vein stenosis (PVS) is an increasingly recognized disease in infants and young children. Controversy exists regarding the best management of this disease. The hallmarks of PVS include recurrence, upstream progression, and spread to previous
Autor:
Divya Suthar, Asaad Beshish, Amanda S Thomas, J'Neka Claxton, Jessica Knight, Fawwaz Shaw, William T Mahle, Matthew Oster, Lazaros Kochilas
Publikováno v:
Circulation. 144
Introduction: Fontan procedure for single ventricle (SV) is frequently preceded by cardiac catheterization. The impact of pre-Fontan hemodynamics on long-term outcomes is not completely understood. Methods: This is a cohort study of patients undergoi
Autor:
Rosemary Gray, Amanda S. Thomas, Christopher J. Petit, Shannon Jones, Jay D. Patel, Divya Suthar, Joelle Pettus, Michael Briones, Courtney McCracken, Mansi Mandhani
Publikováno v:
Journal of the American College of Cardiology. 77(22)
Background Anatomic interventions for pulmonary vein stenosis (PVS) in infants and children have been met with limited success. Sirolimus, a mammalian target of rapamycin inhibitor, has demonstrated promise as a primary medical therapy for PVS, but t
Publikováno v:
Circulation. 138:2718-2720
Autor:
Michael Glenn O’Connor, Divya Suthar, Candice D. Fike, Paul E. Moore, Natalie L. Maitre, Eric D. Austin, Steven Steele, Amy Beller, Judy L. Aschner, James C. Slaughter, Kimberly Vera
Publikováno v:
Pediatric Pulmonology. 53:302-309
Objective Extremely low gestational age neonates (ELGANs) are at risk for pulmonary hypertension (PH). We hypothesized that PH, defined by echocardiogram at 36 weeks gestational age (GA), would associate with respiratory morbidity, increased oxidant